Misplaced Pages

Thomas McGlashan: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively← Previous editNext edit →Content deleted Content addedVisualWikitext
Revision as of 02:21, 21 February 2007 editPernambuco (talk | contribs)1,533 edits DOB← Previous edit Revision as of 02:22, 21 February 2007 edit undoPernambuco (talk | contribs)1,533 edits rephrasingNext edit →
Line 1: Line 1:
Dr. '''Thomas McGlashan''' (born 1942) is a professor of ] at ]. According to the ], ], ], McGlashan "strived for years to master ], only to reject it outright after demonstrating, in a landmark ] study, that the treatment did not help much at all in people ... with ]." Dr. '''Thomas McGlashan''' (born 1942) is a professor of ] at ]. According to the ], ], ], McGlashan "strived for years to master ], only to reject it outright after demonstrating, in a landmark ] study, that the treatment did not help much at all in people ... with ]."


Disappointed with psychoanalysis, Dr. McGlashan then studied the benefits of antipsychotic medical drugs. In the 1990's he embarked on a study of how useful such drugs can be in preventing ] in adolescents at high risk. In May ], "Dr. McGlashan reported that the drugs were more likely to induce weight gain than to produce a significant, measurable benefit." Disappointed with psychoanalysis, Dr. McGlashan then studied the benefits of antipsychotic medical drugs. In the 1990's he embarked on a study the effect of such drugs in preventing ] in adolescents at high risk. In May ], McGlashan reported that "the drugs were more likely to induce weight gain than to produce a significant, measurable benefit."




Revision as of 02:22, 21 February 2007

Dr. Thomas McGlashan (born 1942) is a professor of psychiatry at Yale University. According to the New York Times, May 23, 2006, McGlashan "strived for years to master psychoanalysis, only to reject it outright after demonstrating, in a landmark 1984 study, that the treatment did not help much at all in people ... with schizophrenia."

Disappointed with psychoanalysis, Dr. McGlashan then studied the benefits of antipsychotic medical drugs. In the 1990's he embarked on a study the effect of such drugs in preventing psychosis in adolescents at high risk. In May 2006, McGlashan reported that "the drugs were more likely to induce weight gain than to produce a significant, measurable benefit."


Stub icon

This psychology-related article is a stub. You can help Misplaced Pages by expanding it.

Category: